Melanocytic nevus historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 9: Line 9:
==Historical Perspective==
==Historical Perspective==


* Dysplastic nevi were first reported in 1978 by Clark and colleagues(1) and shortly thereafter by Lynch and colleagues(2, 3) as histologically defined lesions in melanoma-prone families, there has been acrimonious debate about the definition, classification, and biological importance of these lesions. The initial names used by Clark and colleagues were BK moles (and BK mole syndrome), named after two of the first melanoma-prone families seen with these lesions, and familial atypical multiple moles and melanoma syndrome (FAMMM) by Lynch and colleagues(1-4). Subsequently, the term ‘dysplastic nevus’ (and dysplastic nevus syndrome (DNS)) was proposed since these benign melanocytic nevi are characterized by architectural disorder and cytologic atypia, similar to dysplastic lesions in other organs, such as the cervix or esophagus(4-6).<br />
* Dysplastic nevi were first reported in 1978 by Clark and colleagues
*and shortly thereafter by Lynch and colleagues
*as histologically defined lesions in melanoma-prone families, there has been acrimonious debate about the definition, classification, and biological importance of these lesions. The initial names used by Clark and colleagues were BK moles (and BK mole syndrome), named after two of the first melanoma-prone families seen with these lesions, and familial atypical multiple moles and melanoma syndrome (FAMMM) by Lynch and colleagues(1-4). Subsequently, the term ‘dysplastic nevus’ (and dysplastic nevus syndrome (DNS)) was proposed since these benign melanocytic nevi are characterized by architectural disorder and cytologic atypia, similar to dysplastic lesions in other organs, such as the cervix or esophagus(4-6).<br />


==References==
==References==

Revision as of 17:58, 10 October 2019

Melanocytic nevus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Melanocytic Nevus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Melanocytic nevus historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Melanocytic nevus historical perspective

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Melanocytic nevus historical perspective

CDC on Melanocytic nevus historical perspective

Melanocytic nevus historical perspective in the news

Blogs on Melanocytic nevus historical perspective

Directions to Hospitals Treating Melanocytic nevus

Risk calculators and risk factors for Melanocytic nevus historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: : Qurrat-ul-ain Abid, M.D.[2], Martin I. Newman, M.D., FACS, Cleveland Clinic Florida, [3]; Michel C. Samson, M.D., FRCSC, FACS [4]

Overview

At one time in the 1950s and 60s, (and, to a lesser extent, currently) a mole was known as a “beauty mark” when it appeared in certain spots on a woman’s face. Examples include Marilyn Monroe, model Cindy Crawford, and singer Madonna. Madonna's facial mole -- below her right nostril -- has been surgically removed.

Historical Perspective

  • Dysplastic nevi were first reported in 1978 by Clark and colleagues
  • and shortly thereafter by Lynch and colleagues
  • as histologically defined lesions in melanoma-prone families, there has been acrimonious debate about the definition, classification, and biological importance of these lesions. The initial names used by Clark and colleagues were BK moles (and BK mole syndrome), named after two of the first melanoma-prone families seen with these lesions, and familial atypical multiple moles and melanoma syndrome (FAMMM) by Lynch and colleagues(1-4). Subsequently, the term ‘dysplastic nevus’ (and dysplastic nevus syndrome (DNS)) was proposed since these benign melanocytic nevi are characterized by architectural disorder and cytologic atypia, similar to dysplastic lesions in other organs, such as the cervix or esophagus(4-6).

References


Template:WikiDoc Sources